Cancer Biology and Genomic for Disease Diagnosis |
http://pharmaceuticalintelligence.com/biomed-e-books/cancer-biology-and-genomics-for-disease-diagnosis/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title |
Hyperlink |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Binding of Oligonucleotides in DNA and 3-D Lattice Structures |
http://pharmaceuticalintelligence.com/2013/05/15/the-binding-of-oligonucleotides-in-dna-and-3-d-lattice-structures/ |
|
|
|
|
|
|
|
AT13148 – A Novel Oral Multi-AGC Kinase Inhibitor Has Potent Antitumor Activity |
http://pharmaceuticalintelligence.com/2013/05/16/at13148-a-novel-oral-multi-agc-kinase-inhibitor-has-potent-antitumor-activity/ |
|
|
|
|
|
|
The Development of siRNA-Based Therapies for Cancer |
http://pharmaceuticalintelligence.com/2013/05/09/the-development-of-sirna-based-therapies-for-cancer/ |
|
|
|
|
|
|
|
|
|
CD47: Target Therapy for Cancer |
http://pharmaceuticalintelligence.com/2013/05/07/cd47-target-therapy-for-cancer/ |
|
|
|
|
|
|
|
|
|
|
Colon Cancer |
http://pharmaceuticalintelligence.com/2013/04/30/colon-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
|
Ultrasound-based Screening for Ovarian Cancer |
http://pharmaceuticalintelligence.com/2013/04/28/ultrasound-based-screening-for-ovarian-cancer/ |
|
|
|
|
|
|
|
|
|
Association between Non-melanoma Skin Cancer and subsequent Primary Cancers in White Population |
http://pharmaceuticalintelligence.com/2013/04/24/association-between-non-melanoma-skin-cancer-and-subsequent-primary-cancers-in-white-population/ |
|
|
|
|
Tamoxifen’s Effectiveness: Decrease in Tissue Density by Mammography – 50% Lower Risk of Dying from Breast Cancer |
http://pharmaceuticalintelligence.com/2013/04/23/tamoxifens-effectiveness-decrease-in-tissue-density-by-mammography-50-lower-risk-of-dying-from-breast-cancer/ |
|
|
|
Whole exome somatic mutations analysis of malignant melanoma contributes to the development of personalized cancer therapy for this disease |
http://pharmaceuticalintelligence.com/2013/04/23/whole-exome-somatic-mutations-analysis-of-malignant-melanoma-contributes-to-the-development-of-personalized-cancer-therapy-for-this-disease/ |
|
DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD |
http://pharmaceuticalintelligence.com/2013/04/22/dna-methultransferases-implications-to-epigenetic-regulation-and-cancer-therapy-targeting-james-shen-phd/ |
|
|
|
|
System Pharmacology: Using CellMiner and the NCI-60 Cancerous Cell Lines: William Reinhold, PhD |
http://pharmaceuticalintelligence.com/2013/04/22/system-pharmacology-using-cellminer-and-the-nci-60-cancerous-cell-lines-william-reinhold-phd/ |
|
|
|
|
|
Genotype-based Analysis for Cancer Therapy using Large-scale Data Modeling: Nayoung Kim, PhD(c) |
http://pharmaceuticalintelligence.com/2013/04/22/genotype-based-analysis-for-cancer-therapy-using-large-scale-data-modeling-nayoung-kim-phdc/ |
|
|
|
|
|
Molecular Profiling in Cancer Immunotherapy: Debraj GuhaThakurta, PhD |
http://pharmaceuticalintelligence.com/2013/04/22/molecular-profiling-in-cancer-immunotherapy/ |
|
|
|
|
|
|
|
|
|
Mesothelin: An early detection biomarker for cancer (By Jack Andraka) |
http://pharmaceuticalintelligence.com/2013/04/21/mesothelin-an-early-detection-biomarker-for-cancer-by-jack-andraka/ |
|
|
|
|
|
|
|
Cancer Genomic Precision Therapy: Digitized Tumor’s Genome (WGSA) Compared with Genome-native Germ Line: Flash-frozen specimen and Formalin-fixed paraffin-embedded Specimen Needed |
http://pharmaceuticalintelligence.com/2013/04/21/cancer-genomic-precision-therapy-digitized-tumors-genome-wgsa-compared-with-genome-native-germ-line-flash-frozen-specimen-and-formalin-fixed-paraffin-embedded-specimen-needed/ |
Heroes in Medical Research: Dr. Robert Ting, Ph.D. and Retrovirus in AIDS and Cancer |
http://pharmaceuticalintelligence.com/2013/04/17/heroes-in-medical-research-dr-robert-ting-ph-d-and-retrovirus-in-aids-and-cancer/ |
|
|
|
|
|
|
Critical Gene in Calcium Reabsorption: Variants in the KCNJ and SLC12A1 genes – Calcium Intake and Cancer Protection |
http://pharmaceuticalintelligence.com/2013/04/12/critical-gene-in-calcium-reabsorption-variants-in-the-kcnj-and-slc12a1-genes-calcium-intake-and-cancer-protection/ |
|
|
|
2013 American Cancer Research Association Award for Outstanding Achievement in Chemistry in Cancer Research: Professor Alexander Levitzki |
http://pharmaceuticalintelligence.com/2013/04/12/2013-american-cancer-research-association-award-for-outstanding-achievement-in-chemistry-in-cancer-research-professor-alexander-levitzki-chosen/ |
Pancreatic Cancer: Genetics, Genomics and Immunotherapy |
http://pharmaceuticalintelligence.com/2013/04/11/update-on-pancreatic-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
Issues in Personalized Medicine in Cancer: Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing |
http://pharmaceuticalintelligence.com/2013/04/10/issues-in-personalized-medicine-in-cancer-intratumor-heterogeneity-and-branched-evolution-revealed-by-multiregion-sequencing/ |
|
|
Amiodarone Linked to Cancer Risk in Men |
http://pharmaceuticalintelligence.com/2013/04/08/amiodarone-linked-to-cancer-risk-in-men/ |
|
|
|
|
|
|
|
|
|
|
Beta-Blockers help in better survival in ovarian cancer |
http://pharmaceuticalintelligence.com/2013/04/08/beta-blockers-help-in-better-survival-in-ovarian-cancer/ |
|
|
|
|
|
|
|
|
Targeting Mitochondrial-bound Hexokinase for Cancer Therapy |
http://pharmaceuticalintelligence.com/2013/04/06/targeting-mitochondrial-bound-hexokinase-for-cancer-therapy/ |
|
|
|
|
|
|
|
|
zebrafish—susceptible to cancer |
http://pharmaceuticalintelligence.com/2013/04/02/zebrafish-susceptible-to-cancer/ |
|
|
|
|
|
|
|
|
|
|
Acute Lymphoblastic Leukemia and Bone Marrow Transplantation |
http://pharmaceuticalintelligence.com/2013/03/27/acute-lymphoblastic-leukemia-and-bone-marrow-transplantation/ |
|
|
|
|
|
|
|
In Focus: Targeting of Cancer Stem Cells |
http://pharmaceuticalintelligence.com/2013/03/27/in-focus-targeting-of-cancer-stem-cells/ |
|
|
|
|
|
|
|
|
|
|
Ethical Concerns in Personalized Medicine: BRCA1/2 Testing in Minors and Communication of Breast Cancer Risk |
http://pharmaceuticalintelligence.com/2013/03/27/ethical-concerns-in-personalized-medicine-brca12-testing-in-minors-and-communication-of-breast-cancer-risk/ |
|
|
|
|
Cancer Screening at Sourasky Medical Center Cancer Prevention Center in Tel-Aviv |
http://pharmaceuticalintelligence.com/2013/03/25/tel-aviv-sourasky-medical-center-cancer-prevention-center-excellent-example-for-adopting-prevention-of-cancer-as-a-mean-of-fighting-it/ |
|
New Ecosystem of Cancer Research: Cross Institutional Team Science |
http://pharmaceuticalintelligence.com/2013/03/24/new-ecosystem-of-cancer-research-cross-institutional-team-science/ |
|
|
|
|
|
|
|
In Focus: Identity of Cancer Stem Cells |
http://pharmaceuticalintelligence.com/2013/03/22/in-focus-identity-of-cancer-stem-cells/ |
|
|
|
|
|
|
|
|
|
|
Imaging Guided Cancer-Therapy – a Discipline in Need of Guidance |
http://pharmaceuticalintelligence.com/2013/03/22/imaging-guided-cancer-therapy-a-discipline-in-need-of-guidance/ |
|
|
|
|
|
|
|
|
How Might Sleep Apnea Lead to Serious Health Concerns like Cardiac and Cancers? |
http://pharmaceuticalintelligence.com/2013/03/20/how-might-sleep-apnea-lead-to-serious-health-concerns-like-cardiac-and-cancers/ |
|
|
|
|
|
|
The Importance of Cancer Prevention Programs: New Percpectives for Fighting Cancer |
http://pharmaceuticalintelligence.com/2013/03/07/the-importance-of-cancer-prevention-programs-new-perceptions-for-fighting-cancer/ |
|
|
|
|
|
|
Breast Cancer and Mitochondrial Mutations |
http://pharmaceuticalintelligence.com/2013/03/04/breast-cancer-and-mitochondrial-mutations/ |
|
|
|
|
|
|
|
|
|
Treatment for Metastatic HER2 Breast Cancer |
http://pharmaceuticalintelligence.com/2013/03/03/treatment-for-metastatic-her2-breast-cancer/ |
|
|
|
|
|
|
|
|
|
Cancer drugs proving worth |
http://pharmaceuticalintelligence.com/2013/03/02/cancer-drugs-proving-worth/ |
|
|
|
|
|
|
|
|
|
|
|
recurrence risk for breast cancer |
http://pharmaceuticalintelligence.com/2013/03/02/recurrence-risk-for-breast-cancer/ |
|
|
|
|
|
|
|
|
|
|
“Thymosin alpha1 and melanoma” |
http://pharmaceuticalintelligence.com/2013/02/15/thymosin-alpha1-in-melanoma/ |
|
|
|
|
|
|
|
|
|
|
Prostate Cancer: Androgen-driven “Pathomechanism” in Early-onset Forms of the Disease |
http://pharmaceuticalintelligence.com/2013/02/14/prostate-cancer-androgen-driven-pathomechanism-in-early-onset-forms-of-the-disease/ |
|
|
|
|
|
|
Global Burden of Cancer Treatment & Women Health: Market Access & Cost Concerns |
http://pharmaceuticalintelligence.com/2013/02/10/global-burden-of-cancer-treatment-women-health-market-access-cost-concerns/ |
|
|
|
|
|
|
Prostate Cancer and Nanotecnology |
http://pharmaceuticalintelligence.com/2013/02/07/prostate-cancer-and-nanotecnology/ |
|
|
|
|
|
|
|
|
|
|
Winning Over Cancer Progression: New Oncology Drugs to Suppress Passengers Mutations vs. Driver Mutations |
http://pharmaceuticalintelligence.com/2013/02/05/winning-over-cancer-progression-new-oncology-drugs-to-suppress-driver-mutations-vs-passengers-mutations/ |
|
|
|
|
Hold on. Mutations in Cancer do good |
http://pharmaceuticalintelligence.com/2013/02/04/hold-on-mutations-in-cancer-do-good/ |
|
|
|
|
|
|
|
|
|
|
State of the art in oncologic imaging of Colorectal cancers |
http://pharmaceuticalintelligence.com/2013/02/02/state-of-the-art-in-oncologic-imaging-of-colorectal-cancers/ |
|
|
|
|
|
|
|
|
In focus: Triple Negative Breast Cancer |
http://pharmaceuticalintelligence.com/2013/01/29/in-focus-triple-negative-breast-cancer/ |
|
|
|
|
|
|
|
|
|
|
Novel Cancer Hypothesis Suggests Antioxidants Are Harmful |
http://pharmaceuticalintelligence.com/2013/01/27/novel-cancer-hypothesis-suggests-antioxidants-are-harmful/ |
|
|
|
|
|
|
|
|
Ovarian Cancer and fluorescence-guided surgery: A report |
http://pharmaceuticalintelligence.com/2013/01/19/ovarian-cancer-and-fluorescence-guided-surgery-a-report/ |
|
|
|
|
|
|
|
|
Mechanism involved in Breast Cancer Cell Growth: Function in Early Detection & Treatment |
http://pharmaceuticalintelligence.com/2013/01/17/mechanism-involved-in-breast-cancer-cell-growth-function-in-early-detection-treatment/ |
|
|
|
|
|
|
Role of Primary Cilia in Ovarian Cancer |
http://pharmaceuticalintelligence.com/2013/01/15/role-of-primary-cilia-in-ovarian-cancer-2/ |
|
|
|
|
|
|
|
|
|
|
Exploring the role of vitamin C in Cancer therapy |
http://pharmaceuticalintelligence.com/2013/01/15/exploring-the-role-of-vitamin-c-in-cancer-therapy/ |
|
|
|
|
|
|
|
|
|
LEADERS in Genome Sequencing of Genetic Mutations for Therapeutic Drug Selection in Cancer Personalized Treatment: Part 2 |
http://pharmaceuticalintelligence.com/2013/01/13/leaders-in-genome-sequencing-of-genetic-mutations-for-therapeutic-drug-selection-in-cancer-personalized-treatment-part-2/ |
|
|
Harnessing Personalized Medicine for Cancer Management, Prospects of Prevention and Cure: Opinions of Cancer Scientific Leaders @ http://pharmaceuticalintelligence.com |
http://pharmaceuticalintelligence.com/2013/01/12/harnessing-personalized-medicine-for-cancer-management-prospects-of-prevention-and-cure-opinions-of-cancer-scientific-leaders-httppharmaceuticalintelligence-com/ |
Inspiration From Dr. Maureen Cronin’s Achievements in Applying Genomic Sequencing to Cancer Diagnostics |
http://pharmaceuticalintelligence.com/2013/01/10/inspiration-from-dr-maureen-cronins-achievements-in-applying-genomic-sequencing-to-cancer-diagnostics/ |
|
|
|
|
“The Molecular pathology of Breast Cancer Progression” |
http://pharmaceuticalintelligence.com/2013/01/10/the-molecular-pathology-of-breast-cancer-progression/ |
|
|
|
|
|
|
|
|
The “Cancer establishments” examined by James Watson, co-discoverer of DNA w/Crick, 4/1953 |
http://pharmaceuticalintelligence.com/2013/01/09/the-cancer-establishments-examined-by-james-watson-co-discover-of-dna-wcrick-41953/ |
|
|
|
|
|
|
New Imaging device bears a promise for better quality control of breast-cancer lumpectomies – considering the cost impact |
http://pharmaceuticalintelligence.com/2013/01/09/new-imaging-device-bears-a-promise-for-better-quality-control-of-breast-cancer-lumpectomies-considering-the-cost-impact/ |
|
|
|
Not applying evidence-based medicine drives up the costs of screening for breast-cancer in the USA. |
http://pharmaceuticalintelligence.com/2013/01/08/6911/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Personalized medicine gearing up to tackle cancer |
http://pharmaceuticalintelligence.com/2013/01/07/personalized-medicine-gearing-up-to-tackle-cancer/ |
|
|
|
|
|
|
|
|
|
Whole-body imaging as cancer screening tool; answering an unmet clinical need? |
http://pharmaceuticalintelligence.com/2013/01/03/whole-body-imaging-as-cancer-screening-tool-answering-an-unmet-clinical-need/ |
|
|
|
|
|
|
Stanniocalcin: A Cancer Biomarker. |
http://pharmaceuticalintelligence.com/2012/12/25/stanniocalcin-a-cancer-biomarker/ |
|
|
|
|
|
|
|
|
|
|
Breast Cancer: Genomic profiling to predict Survival: Combination of Histopathology and Gene Expression Analysis |
http://pharmaceuticalintelligence.com/2012/12/24/breast-cancer-genomic-profiling-to-predict-survival-combination-of-histopathology-and-gene-expression-analysis/ |
|
|
|
Optical Coherent Tomography – emerging technology in cancer patient management |
http://pharmaceuticalintelligence.com/2012/12/24/optical-coherent-tomography-emerging-technology-in-cancer-patient-management/ |
|
|
|
|
|
|
Gastric Cancer: Whole-genome reconstruction and mutational signatures |
http://pharmaceuticalintelligence.com/2012/12/24/gastric-cancer-whole-genome-reconstruction-and-mutational-signatures-2/ |
|
|
|
|
|
|
|
Nanotechnology: Detecting and Treating metastatic cancer in the lymph node |
http://pharmaceuticalintelligence.com/2012/12/19/nanotechnology-detecting-and-treating-metastatic-cancer-in-the-lymph-node/ |
|
|
|
|
|
|
Nanotech Therapy for Breast Cancer |
http://pharmaceuticalintelligence.com/2012/12/09/naotech-therapy-for-breast-cancer/ |
|
|
|
|
|
|
|
|
|
|
Dasatinib in Combination With Other Drugs for Advanced, Recurrent Ovarian Cancer |
http://pharmaceuticalintelligence.com/2012/12/08/dasatinib-in-combination-with-other-drugs-for-advanced-recurrent-ovarian-cancer/ |
|
|
|
|
|
|
Squeezing Ovarian Cancer Cells to Predict Metastatic Potential: Cell Stiffness as Possible Biomarker |
http://pharmaceuticalintelligence.com/2012/12/08/squeezing-ovarian-cancer-cells-to-predict-metastatic-potential-cell-stiffness-as-possible-biomarker/ |
|
|
|
|
|
BRCA1 a tumour suppressor in breast and ovarian cancer – functions in transcription, ubiquitination and DNA repair |
http://pharmaceuticalintelligence.com/2012/12/04/brca1-a-tumour-suppressor-in-breast-and-ovarian-cancer-functions-in-transcription-ubiquitination-and-dna-repair/ |
|
|
|
Diagnosing lung cancer in exhaled breath using gold nanoparticles |
http://pharmaceuticalintelligence.com/2012/12/01/diagnosing-lung-cancer-in-exhaled-breath-using-gold-nanoparticles/ |
|
|
|
|
|
|
|
Personalized Medicine: Cancer Cell Biology and Minimally Invasive Surgery (MIS) |
http://pharmaceuticalintelligence.com/2012/12/01/personalized-medicine-cancer-cell-biology-and-minimally-invasive-surgery-mis/ |
|
|
|
|
|
|
Prostate Cancer Cells: Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition |
http://pharmaceuticalintelligence.com/2012/11/30/histone-deacetylase-inhibitors-induce-epithelial-to-mesenchymal-transition-in-prostate-cancer-cells/ |
|
|
|
|
|
PIK3CA mutation in Colorectal Cancer may serve as a Predictive Molecular Biomarker for adjuvant Aspirin therapy |
http://pharmaceuticalintelligence.com/2012/11/28/pik3ca-mutation-in-colorectal-cancer-may-serve-as-a-predictive-molecular-biomarker-for-adjuvant-aspirin-therapy/ |
|
|
|
Nanotechnology Tackles Brain Cancer |
http://pharmaceuticalintelligence.com/2012/11/23/nanotechnology-tackles-brain-cancer/ |
|
|
|
|
|
|
|
|
|
|
Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling: a MED12 Control |
http://pharmaceuticalintelligence.com/2012/11/21/response-to-multiple-cancer-drugs-through-regulation-of-tgf-%CE%B2-receptor-signaling-a-med12-control/ |
|
|
|
|
Personalized medicine-based cure for cancer might not be far away |
http://pharmaceuticalintelligence.com/2012/11/20/personalized-medicine-based-cure-for-cancer-might-not-be-far-away/ |
|
|
|
|
|
|
|
GSK for Personalized Medicine using Cancer Drugs needs Alacris systems biology model to determine the in silico effect of the inhibitor in its “virtual clinical trial” |
http://pharmaceuticalintelligence.com/2012/11/14/gsk-for-personalized-medicine-using-cancer-drugs-needs-alacris-systems-biology-model-to-determine-the-in-silico-effect-of-the-inhibitor-in-its-virtual-clinical-trial/ |
Lung Cancer (NSCLC), drug administration and nanotechnology |
http://pharmaceuticalintelligence.com/2012/11/08/lung-cancer-nsclc-drug-administration-and-nanotechnology/ |
|
|
|
|
|
|
|
|
Non-small Cell Lung Cancer drugs – where does the Future lie? |
http://pharmaceuticalintelligence.com/2012/11/06/non-small-cell-lung-cancer-drugs-where-does-the-future-lie/ |
|
|
|
|
|
|
|
|
Cancer Innovations from across the Web |
http://pharmaceuticalintelligence.com/2012/11/02/cancer-innovations-from-across-the-web/ |
|
|
|
|
|
|
|
|
|
|
arrayMap: Genomic Feature Mining of Cancer Entities of Copy Number Abnormalities (CNAs) Data |
http://pharmaceuticalintelligence.com/2012/11/01/arraymap-genomic-feature-mining-of-cancer-entities-of-copy-number-abnormalities-cnas-data/ |
|
|
|
|
|
How mobile elements in “Junk” DNA promote cancer. Part 1: Transposon-mediated tumorigenesis. |
http://pharmaceuticalintelligence.com/2012/10/31/how-mobile-elements-in-junk-dna-prote-cacner-part1-transposon-mediated-tumorigenesis/ |
|
|
|
|
|
Cancer Genomics – Leading the Way by Cancer Genomics Program at UC Santa Cruz |
http://pharmaceuticalintelligence.com/2012/10/29/cancer-genomics-leading-the-way-by-cancer-genomics-program-at-uc-santa-cruz/ |
|
|
|
|
|
|
Closing the gap towards real-time, imaging-guided treatment of cancer patients. |
http://pharmaceuticalintelligence.com/2012/10/27/closing-the-gap-towards-real-time-imaging-guided-treatment-of-cancer-patients/ |
|
|
|
|
|
|
Lipid Profile, Saturated Fats, Raman Spectrosopy, Cancer Cytology |
http://pharmaceuticalintelligence.com/2012/10/26/lipid-profile-saturated-fats-raman-spectrosopy-cancer-cytology/ |
|
|
|
|
|
|
|
|
mRNA interference with cancer expression |
http://pharmaceuticalintelligence.com/2012/10/26/mrna-interference-with-cancer-expression/ |
|
|
|
|
|
|
|
|
|
Pancreatic cancer genomes: Axon guidance pathway genes – aberrations revealed |
http://pharmaceuticalintelligence.com/2012/10/24/pancreatic-cancer-genomes-axon-guidance-pathway-genes-aberrations-revealed/ |
|
|
|
|
|
|
Biomarker tool development for Early Diagnosis of Pancreatic Cancer: Van Andel Institute and Emory University |
http://pharmaceuticalintelligence.com/2012/10/24/biomarker-tool-development-for-early-diagnosis-of-pancreatic-cancer-van-andel-institute-and-emory-university/ |
|
|
|
|
The unfortunate ending of the Tower of Babel construction project and its effect on modern imaging-based cancer patients’ management |
http://pharmaceuticalintelligence.com/2012/10/22/the-unfortunate-ending-of-the-tower-of-babel-construction-project-and-its-effect-on-modern-imaging-based-cancer-patients-management/ |
|
Stomach Cancer Subtypes Methylation-based identified by Singapore-Led Team |
http://pharmaceuticalintelligence.com/2012/10/17/stomach-cancer-subtypes-methylation-based-identified-by-singapore-led-team/ |
|
|
|
|
|
|
Is the Warburg Effect the cause or the effect of cancer: A 21st Century View? |
http://pharmaceuticalintelligence.com/2012/10/17/is-the-warburg-effect-the-cause-or-the-effect-of-cancer-a-21st-century-view/ |
|
|
|
|
|
|
|
Crucial role of Nitric Oxide in Cancer |
http://pharmaceuticalintelligence.com/2012/10/16/crucial-role-of-nitric-oxide-in-cancer/ |
|
|
|
|
|
|
|
|
|
|
Personalized Pancreatic Cancer Treatment Option |
http://pharmaceuticalintelligence.com/2012/10/16/personalized-pancreatic-cancer-treatment-option/ |
|
|
|
|
|
|
|
|
|
Targeting Glucose Deprived Network Along with Targeted Cancer Therapy Can be a Possible Method of Treatment |
http://pharmaceuticalintelligence.com/2012/10/15/targeting-glucose-deprived-network-along-with-targeted-cancer-therapy-can-be-a-possible-method-of-treatment/ |
|
|
|
Increased risks of obesity and cancer, Decreased risk of type 2 diabetes: The role of Tumor-suppressor phosphatase and tensin homologue (PTEN) |
http://pharmaceuticalintelligence.com/2012/10/01/increased-risks-of-obesity-and-cancer-decreased-risk-of-type-2-diabetes-the-role-of-tumor-suppressor-phosphatase-and-tensin-homologue-pten/ |
|
Warning signs may lead to better early detection of ovarian cancer |
http://pharmaceuticalintelligence.com/2012/09/23/warning-signs-may-lead-to-better-early-detection-of-ovarian-cancer/ |
|
|
|
|
|
|
|
Breast Cancer, drug resistance, and biopharmaceutical targets |
http://pharmaceuticalintelligence.com/2012/09/18/breast-cancer-drug-resistance-and-biopharmaceutical-targets/ |
|
|
|
|
|
|
|
|
Head and Neck Cancer Studies Suggest Alternative Markers More Prognostically Useful than HPV DNA Testing |
http://pharmaceuticalintelligence.com/2012/09/18/head-and-neck-cancer-studies-suggest-alternative-markers-more-prognostically-useful-than-hpv-dna-testing/ |
|
|
|
|
Imaging agent to detect Prostate cancer-now a reality |
http://pharmaceuticalintelligence.com/2012/09/18/imaging-agent-to-detect-prostate-cancer-now-a-reality/ |
|
|
|
|
|
|
|
|
Scientists use natural agents for prostate cancer bone metastasis treatment |
http://pharmaceuticalintelligence.com/2012/09/17/natural-agents-for-prostate-cancer-bone-metastasis-treatment/ |
|
|
|
|
|
|
|
|
β Integrin emerges as an important player in mitochondrial dysfunction associated Gastric Cancer |
http://pharmaceuticalintelligence.com/2012/09/10/%CE%B2-integrin-emerges-as-an-important-player-in-mitochondrial-dysfunction-associated-gastric-cancer/ |
|
|
|
|
Comprehensive Genomic Characterization of Squamous Cell Lung Cancers |
http://pharmaceuticalintelligence.com/2012/09/10/comprehensive-genomic-characterization-of-squamous-cell-lung-cancers/ |
|
|
|
|
|
|
|
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 |
http://pharmaceuticalintelligence.com/2012/09/10/targeted-tumor-penetrating-sirna-nanocomplexes-for-credentialing-the-ovarian-cancer-oncogene-id4/ |
|
|
|
|
Today’s fundamental challenge in Prostate cancer screening |
http://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/ |
|
|
|
|
|
|
|
|
Asthma Drug Prevents Spread of Breast Cancer, Study Finds |
http://pharmaceuticalintelligence.com/2012/09/01/asthma-drug-prevents-spread-of-breast-cancer-study-finds/ |
|
|
|
|
|
|
|
|
Marijuana Compound Shows Promise In Fighting Breast Cancer |
http://pharmaceuticalintelligence.com/2012/09/01/marijuana-compound-shows-promise-in-fighting-breast-cancer/ |
|
|
|
|
|
|
|
|
Cell Movement Provides Clues to Aggressive Breast Cancer |
http://pharmaceuticalintelligence.com/2012/09/01/cell-movement-provides-clues-to-aggressive-breast-cancer/ |
|
|
|
|
|
|
|
|
Identifying Aggressive Breast Cancers by Interpreting the Mathematical Patterns in the Cancer Genome |
http://pharmaceuticalintelligence.com/2012/09/01/identifying-aggressive-breast-cancers-by-interpreting-the-mathematical-patterns-in-the-cancer-genome/ |
|
|
|
|
Carboranes to aid the ability of the cancer drug |
http://pharmaceuticalintelligence.com/2012/09/01/carboranes-to-aid-the-ability-of-the-cancer-drug/ |
|
|
|
|
|
|
|
|
|
ROLE OF VIRAL INFECTION IN PROSTATE CANCER |
http://pharmaceuticalintelligence.com/2012/09/01/role-of-viral-infection-in-prostate-cancer/ |
|
|
|
|
|
|
|
|
|
|
Mitochondria and Cancer: An overview of mechanisms |
http://pharmaceuticalintelligence.com/2012/09/01/mitochondria-and-cancer-an-overview/ |
|
|
|
|
|
|
|
|
|
|
After Making Millions, Two 20-Somethings Have Founded A Startup To Help Fight Cancer |
http://pharmaceuticalintelligence.com/2012/08/29/after-making-millions-two-20-somethings-have-founded-a-startup-to-help-fight-cancer/ |
|
|
|
|
|
|
The Incentive for “Imaging based cancer patient’ management” |
http://pharmaceuticalintelligence.com/2012/08/27/the-incentive-for-imaging-based-cancer-patient-management/ |
|
|
|
|
|
|
|
|
Understand how DNA damage is repaired—knowledge that could result in the development of new and more effective drugs for cancer treatment |
http://pharmaceuticalintelligence.com/2012/08/22/understand-how-dna-damage-is-repaired-knowledge-that-could-result-in-the-development-of-new-and-more-effective-drugs-for-cancer-treatment/ |
|
Guidelines for the welfare and use of animals in cancer research |
http://pharmaceuticalintelligence.com/2012/08/22/guidelines-for-the-welfare-and-use-of-animals-in-cancer-research/ |
|
|
|
|
|
|
|
|
Thyroid Cancer: The Evolution of Treatment Options |
http://pharmaceuticalintelligence.com/2012/08/19/thyroid-cancer-the-evolution-of-treatment-options/ |
|
|
|
|
|
|
|
|
|
“To Die or Not To Die” – Time and Order of Combination drugs for Triple Negative Breast Cancer cells: A Systems Level Analysis |
http://pharmaceuticalintelligence.com/2012/08/15/to-die-or-not-to-die-time-and-order-of-combination-drugs-for-triple-negative-breast-cancer-cells-a-systems-level-analysis/ |
|
|
|
Missing Gene may drive more than a quarter of Breast Cancers |
http://pharmaceuticalintelligence.com/2012/08/14/missing-gene-may-drive-more-than-a-quarter-of-breast-cancers/ |
|
|
|
|
|
|
|
|
Aspirin a Day Tied to Lower Cancer Mortality |
http://pharmaceuticalintelligence.com/2012/08/11/1796/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$20 million Novartis deal with ‘University of Pennsylvania’ to develop Ultra-Personalized Cancer Immunotherapy |
http://pharmaceuticalintelligence.com/2012/08/08/20-million-novartis-deal-with-university-of-pennsylvania-to-develop-ultra-personalized-cancer-immunotherapy/ |
|
|
|
|
Prostate Cancers Plunged After USPSTF Guidance, Will It Happen Again? |
http://pharmaceuticalintelligence.com/2012/07/31/prostate-cancers-plunged-after-uspstf-guidance-will-it-happen-again/ |
|
|
|
|
|
|
|
Medicines in Development for Cancer in 2012: An Excellent Response from America’s Biopharmaceutical Research Companies |
http://pharmaceuticalintelligence.com/2012/07/31/medicines-in-development-for-cancer-in-2012-an-excellent-response-from-americas-biopharmaceutical-research-companies/ |
|
|
Men With Prostate Cancer More Likely to Die from Other Causes |
http://pharmaceuticalintelligence.com/2012/07/29/men-with-prostate-cancer-more-likely-to-die-from-other-causes/ |
|
|
|
|
|
|
|
|
Tumor Cells’ Inner Workings Predict Cancer Progression |
http://pharmaceuticalintelligence.com/2012/07/29/tumor-cells-inner-workings-predict-cancer-progression/ |
|
|
|
|
|
|
|
|
Pfizer’s Kidney Cancer Drug Sutent Effectively caused REMISSION to Adult Acute Lymphoblastic Leukemia (ALL) |
http://pharmaceuticalintelligence.com/2012/07/10/pfizers-kidney-cancer-drug-sutent-effectively-caused-remission-to-adult-acute-lymphoblastic-leukemia-all/ |
|
|
|
|
Melanoma: Molecule in Immune System Could Help Treat Dangerous Skin Cancer |
http://pharmaceuticalintelligence.com/2012/07/08/melanoma-molecule-in-immune-system-could-help-treat-dangerous-skin-cancer/ |
|
|
|
|
|
|
Combination Therapy to Starve Cancer Cells to Death |
http://pharmaceuticalintelligence.com/2012/06/29/combination-therapy-to-starve-cancer-cells-to-death/ |
|
|
|
|
|
|
|
|
|
Cancer and Bone: low magnitude vibrations help mitigate bone loss |
http://pharmaceuticalintelligence.com/2012/06/19/cancer-and-bone-low-magnitude-vibrations-help-mitigate-bone-loss-5-2/ |
|
|
|
|
|
|
|
HBV and HCV-associated Liver Cancer: Important Insights from the Genome |
http://pharmaceuticalintelligence.com/2012/06/04/hbv-and-hcv-associated-liver-cancer-important-insights-from-the-genome/ |
|
|
|
|
|
|
|
New Anti-Cancer Drug Developed |
http://pharmaceuticalintelligence.com/2012/05/30/new-anti-cancer-drug-developed/ |
|
|
|
|
|
|
|
|
|
|
Commonly Used Painkillers May Protect Against Skin Cancer |
http://pharmaceuticalintelligence.com/2012/05/30/commonly-used-painkillers-may-protect-against-skin-cancer/ |
|
|
|
|
|
|
|
|
New Prostate Cancer Screening Guidelines Face a Tough Sell, Study Suggests |
http://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/ |
|
|
|
|
|
|
|
Sleep Apnea Might Cause Serious Health Concerns like Cardiac and Cancers |
http://pharmaceuticalintelligence.com/2012/05/22/sleep-apnea-might-cause-serious-health-concerns-like-cardiac-and-cancers/ |
|
|
|
|
|
|
|
Battle of Steve Jobs and Ralph Steinman with Pancreatic cancer: How we lost |
http://pharmaceuticalintelligence.com/2012/05/21/battle-of-steve-jobs-and-ralph-steinman-with-pancreatic-cancer-how-we-lost/ |
|
|
|
|
|
|
|
Early Biomarker for Pancreatic Cancer Identified |
http://pharmaceuticalintelligence.com/2012/05/17/early-biomarker-for-pancreatic-cancer-identified/ |
|
|
|
|
|
|
|
|
|
All Cancer Cells Are Not Created Equal: Some Cell Types Control Continued Tumor Growth, Others Prepare the Way for Metastasis |
http://pharmaceuticalintelligence.com/2012/05/17/all-cancer-cells-are-not-created-equal-some-cell-types-control-continued-tumor-growth-others-prepare-the-way-for-metastasis/ |
|
|
High Doses of Certain Dietary Supplements Increase Cancer Risk |
http://pharmaceuticalintelligence.com/2012/05/17/high-doses-of-certain-dietary-supplements-increase-cancer-risk/ |
|
|
|
|
|
|
|
|
Usp9x: Promising therapeutic target for pancreatic cancer |
http://pharmaceuticalintelligence.com/2012/05/14/promising-therapeutic-target-discovered-for-pancreatic-cancer/ |
|
|
|
|
|
|
|
|
A Strategy to Handle the Most Aggressive Breast Cancer: Triple-negative Tumors |
http://pharmaceuticalintelligence.com/2012/05/12/a-strategy-to-handle-the-most-aggressive-breast-cancer-triple-negative-tumors/ |
|
|
|
|
|
|
Arthritis, Cancer: New Screening Technique Yields Elusive Compounds to Block Immune-Regulating Enzyme |
http://pharmaceuticalintelligence.com/2012/05/11/arthritis-cancer-new-screening-technique-yields-elusive-compounds-to-block-immune-regulating-enzyme/ |
|
|
|
|
Dimming ovarian cancer growth |
http://pharmaceuticalintelligence.com/2012/05/11/259/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Mystery unveiled about Missing breast cancer genes |
http://pharmaceuticalintelligence.com/2012/05/11/mystery-unveiled-about-missing-breast-cancer-genes/ |
|
|
|
|
|
|
|
|
|
Researchers develop cancer cell-screening biochip to understand the efficacy of especially anti-cancer drugs against CSCs. |
http://pharmaceuticalintelligence.com/2012/05/09/researchers-develop-cancer-cell-screening-biochip-to-understand-the-efficacy-of-especially-anti-cancer-drugs-against-cscs/ |
|
|
|
‘Mosaicism’ is Associated with Aging and Chronic Diseases like Cancer: detection of genetic mosaicism could be an early marker for detecting cancer. |
http://pharmaceuticalintelligence.com/2012/05/08/mosaicism-is-associated-with-aging-and-chronic-diseases-like-cancer-detection-of-genetic-mosaicism-could-be-an-early-marker-for-detecting-cancer/ |
Visualizing breast cancer without X-rays |
http://pharmaceuticalintelligence.com/2012/05/08/visualizing-breast-cancer-without-x-rays/ |
|
|
|
|
|
|
|
|
|
|
10 Facts About Cancer |
http://pharmaceuticalintelligence.com/2012/05/08/10-facts-about-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
What is Cancer? |
http://pharmaceuticalintelligence.com/2012/05/07/what-is-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
|
Leave a Reply